Dietary ingredients used in supplements can be classified as either Old Dietary Ingredients (ODIs) or New Dietary Ingredients (NDIs), depending on whether they were marketed and sold in interstate commerce before October 15, 1994. Our regulatory experts will determine the status of your dietary ingredient, whether old or new, and provide a customized, all-in-one solution to meet NDI compliance. NDI requirements are highly detailed, necessitating expertise in both identity (chemistry) and safety (toxicology). Led by a co-author of the FDA’s NDI draft guidance and a former FDA Branch Chief for Dietary Supplement Regulation Implementation, our team will assist you throughout the entire NDI submission process. Our services include strategy development for filing an NDI notification, technical review of identity specifications, GAP analysis of toxicology data, recommendations for pre-clinical safety studies and their conduct, and direct correspondence with the FDA, including facilitation of a Pre-Notification meeting. KGK Science prepares and submits comprehensive NDI notifications, organizing all necessary safety and scientific data, ensuring your submission is complete, accurate, and positioned for regulatory approval.
Achieving Generally Recognized as Safe (GRAS) status for your ingredients is essential for regulatory compliance and consumer confidence. The Federal Food, Drug, and Cosmetic Act imposes strict safety regulations on food ingredients, and internet-savvy consumers increasingly seek FDA awareness and approval. KGK Science specializes in preparing and submitting GRAS conclusions, providing the scientific evidence needed to support the safety of your ingredients. Our experts, qualified by scientific training and experience, will draft your GRAS conclusion, which can be independently reviewed (self-GRAS), reviewed and submitted to the FDA (FDA GRAS notice), or formally petitioned to the FDA (food additive petition). Our all-in-one customized solution includes technical review and GAP analysis, planning and conducting studies to support identity and safety data, in-house expertise in statistics and food toxicology, and assembling data into a comprehensive dossier. Additionally, a panel of independent expert food scientists will review the GRAS conclusion and provide final sign-off letters, ensuring your submission is thorough, compelling, and positioned for regulatory acceptance.
Bringing a new product to the Canadian market requires obtaining the necessary licenses and approvals from Health Canada, specifically through the Natural and Non-Prescription Health Products Directorate (NNHPD). This regulatory body ensures that Canadians have access to safe, effective, and high-quality natural health products. Securing product licensing through the NNHPD not only meets the legal requirements for selling in Canada but also maximizes the value of efficacy claims in your product marketing. KGK Science’s Canada-based regulatory team, led by an experienced Federal Regulator, will support your business in securing the evidence and assessments needed for product licensing. Our expert services include a technical review of quality specifications, safety and efficacy evidence, and a summary of claims supported by regulatory requirements. We also handle the completion and submission of the Product License Application (PLA), ensuring all documentation meets Health Canada’s stringent standards and facilitating a seamless approval process to help you launch your products with confidence.
In Canada, Natural Health Products (NHPs) are regulated by Health Canada under the Natural Health Products Regulations, which ensure that these products are safe, effective, and of high quality. When introducing a new substance as part of an NHP, manufacturers may need to submit a New Substances Notification (NSN) if the substance has not been previously approved for use in NHPs. KGK Science offers specialized support for companies navigating this regulatory process, ensuring compliance with Health Canada’s requirements for new ingredients.
Determining whether an ingredient can achieve GRAS status is a key consideration in product development. KGK Science provides GRAS feasibility letters, offering a preliminary assessment of the ingredient’s safety and regulatory prospects. This service helps guide your development process, providing an early indication of whether an ingredient is likely to be considered GRAS by regulatory authorities.
Under the Modernization of Cosmetics Regulation Act (MoCRA) of 2022, cosmetic companies are now required to substantiate the safety of their products before marketing. KGK Science offers comprehensive Safety Substantiation services to ensure your products meet FDA requirements. Our expert team assists with:
Post-market surveillance is essential for monitoring the safety of your products once they reach the market, particularly in the nutraceutical and cosmetic industries. KGK Science offers comprehensive Serious Adverse Event Reporting (SAER) services, ensuring compliance with regulatory requirements and protecting consumer safety. Managing SAER can be especially challenging for start-ups, as it requires significant investment in dedicated full-time staff. KGK Science serves as a one-stop shop for all your SAER needs, operating a high-quality Communications Center in London, Ontario, Canada. Our team handles the intake of all reported events from the U.S. and Canada, triaging product complaints and adverse events with the help of qualified healthcare practitioners to assess their severity.
Our SAER services include:
KGK Science has been delivering top-notch clinical research trials and expert regulatory support for the nutraceutical, cannabis, hemp, and psychedelic industries for over 27 years, aiding companies in bringing their products to global markets with custom trials and claim substantiation strategies.
Monday - Saturday 7:00 AM - 3:00 PM